Delivery Order SPE2DB22D2007-SPE2DB25FJ4MS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Rabavert rabies vaccine with diluents. This firm fixed price delivery order, valued at $2,840.90, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by August 26, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,297.80 firm fixed price delivery order for Rabavert rabies vaccine with diluents, effective August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $1,226.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of August 12, 2025. The award was made on August 11, 2025, with no set-aside designation, and performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,257.48 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. The contract, issued September 2, 2025, with completion targeted for September 23, 2025, represents a firm fixed-price procurement with no set-aside designation. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $10,479.00 to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Rabavert rabies vaccine with diluents. This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of September 23, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive role as a critical...
- The Defense Logistics Agency awarded a $41,916 firm fixed price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents on September 2, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside contract represents a competitively awarded delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The IDC serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed-price contract valued at $18,728.13. The order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,702.41 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This firm fixed price delivery order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The contract carries no set-aside designation and was competitively awarded. Performance will take place at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,095.80 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Rabavert rabies vaccine with diluents. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Rabavert rabies vaccine with diluents, valued at $18,968.07. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), represents a non-competitive set-aside procurement. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4MSDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Rabavert rabies vaccine with diluents. This is a firm fixed price delivery order valued at $1,047.90 with a completion date of September 23, 2025. The contract carries no set-aside designation and was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company's IDC with DLA enables supply of a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, syringes, and other critical medical commodities. This specific delivery order for rabies vaccine reflects the company's ongoing role in supporting Defense Health Agency and other government healthcare system requirements through the DLA's comprehensive pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/2/25 |